Future  of  Innova-on  and  Intellectual  Property  

28  November  2013  |  Tim  Jones  

Innova-on  and  Intellectual  Property  Innova6on  is  increasingly  moving  beyond  the  established  arenas  of  

product  and  technology  development  where  IP  has  tradi6onally  had  a  major  role  to  play  -­‐  we  need  to  understand  poten6al  future  impact.  

Looking  Forwards  Organisa6ons  increasingly  want  to  iden6fy  and  understand  both  the  an6cipated  and  unexpected  changes  from  within  and  outside  their  

sector  so  that  they  can  be  beHer  prepared  for  the  future  

Looking  Back    Ten  years  ago  some  saw  the  emerging  shiIs  that  might  have  impact  to  include  the  resurgence  of  patent  pools,  IP  development  companies    and  new  financial  strategies  such  as  Asset  Backed  Securi6za6on  

Companies  of  Note  Over  the  past  decade  many  have  been  surprised  by  shiIs  such  as    

the  success  of  ARM’s  licensing  business  model  and  the  ways  in  which  Amazon  and  Google  have  built  and  exploited  their  IP  porUolios  

0  

200  

400  

600  

800  

1000  

1200  

1400  

2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012  

Amazon  

Google  

#  US  Patents  Granted  (USPTO)  

Future  Agenda  The  Future  Agenda  is  the  world’s  largest  open  foresight    programme  that  engages  expert  input  from  over  1500    organisa6ons  to  beHer  understand  the  next  decade  

1.  Differen6ated  Knowledge    2.  The  End  of  IP    3.  Failed  Drugs    4.  Business  Model  Open  Innova6on    5.  Corporate  LEGO    6.  Projects  Worth  Working  For    7.  Big  Collabora6on    

We  see  seven  issues  that  may  have  significant  future  impact  

Differen-ated  Knowledge  As  informa6on  is  shared  globally  and  insight  is  commodi6zed,  

 the  best  returns  go  to  those  who  can  produce    non-­‐standard,  differen6ated  knowledge.      

The  End  of  IP  Following  change  in  the  music  industry,  technologies  such  as    3D  prin6ng  are  decoupling  the  produc6on  of  content  from    

the  original  creator  and,  in  doing  so,  IP  is  becoming  irrelevant.  

Failed  Drugs    With  pressure  on  ‘big  pharma’  to  deliver  more  effec6ve  R&D,    the  IP  associated  with  drugs  that  fail  in  clinical  trials  is  being    more  openly  shared  for  others  to  find  beneficial  applica6ons.  

Business  Model  Open  Innova-on  Increasing  sector-­‐to-­‐sector  transfer  of  know-­‐how  independent    

of  IP  enables  successful  approaches  to  be  adopted  and    adapted  without  value  transfer  between  par6es.  

Corporate  LEGO    With  more  free  agents  and  outsourcing,  more  func6ons    

within  organiza6ons  are  interchangeable  and  easily  rebuilt    around  new  value-­‐crea6ng  units.  

Projects  Worth  Working  For    In  a  world  where  innova6on  talent  is  global,  fluid  and  aHracted  by    

the  challenge  or  reputa6on  more  than  the  paycheck,  the  winners  will    be  the  organiza6ons  that  provide  the  most  interes6ng  projects.  

Big  Collabora-on    Addressing  future  major  challenges  relies  on  deeper  and    wider  collabora6on  between  organiza6ons  with  no  lead    

company  and  IP  value  crea6on  replaced  by  new  recogni6on.  

More  Informa-on  For  more  details  on  these  thoughts  please  see  the  futureagenda    

website  and  the  second  chapter  in  “Intellectual  Property  Valua6on    and  Innova6on”  recently  published  by  Routledge.  

Intellectual  Property  Valua-on  and  Innova-on  Edited  by  Ruth  Taplin  Hardcover:  208  pages  Publisher:  Routledge  (21  Oct  2013)  ISBN-­‐10:  0415532159  ISBN-­‐13:  978-­‐0415532150  hHp://www.amazon.co.uk/dp/0415532159    

Future  Agenda  84  Brook  Street  London  W1K  5EH  +44  203  0088  141  futureagenda.org  6m.jones@futureagenda.org  

The  world’s  leading  open  foresight  program